Form 10-Q FIBROGEN INC For: Jun 30
- Dow, S&P 500 open higher on lower yields, Apple slides
- Apple Falls 4% on Report It Will Not Ramp Up iPhone 14 Production, Analyst Not Surprised
- Biogen (BIIB) Surges After 'Best-Case' Alzheimer's Drug Trial Results; Stock Earns Several Upgrades
- Europe Stock Outflows 'Worse Than During COVID Panic' - Citi
- S&P 500 Index: Technicals Point Toward New YTD Lows - BofA
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
http://archive.fast-edgar.com/20220808/AP22H222ZC22TJ5S222G2Z42LMAL9K22Z242 Filed on: August 8, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BYD Announces Pre-sale Prices of European Passenger Car Range
- ENG Opens New Fabrication Facility In Brookshire, Texas
- Verismo Therapeutics Receives U.S. FDA Orphan Drug Designation for SynKIR-110™, a First-in-Class KIR-CAR T Cell Immunotherapy Candidate, for the Treatment of Mesothelioma
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!